Modification of tumor suppressor gene expression and induction of apoptosis in non-small cell lung cancer (NSCLC) with an adenovirus vector expressing wildtype p53 and cisplatin

Human Gene Therapy

Volumn 7, Issue 8, 1996, Pages 1013-1030

  Roth, Jack A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; PROTEIN P53;

ADENOVIRUS; ADULT; ARTICLE; ASPIRATION BIOPSY; CANCER THERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG POTENTIATION; EXPRESSION VECTOR; GENE EXPRESSION; GENE THERAPY; HUMAN; INTRATUMORAL DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; THROMBOCYTE COUNT; TUMOR SUPPRESSOR GENE;

EID: 0029890861     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.8-1013     Document Type: Article

References (27)

1. Brown CC, Kessler LG. Projections of lung cancer mortality in the United States: 1985-2025. J Natl Cancer Inst 1988; 80:43.
2. Bishop JM. Molecular themes in oncogenesis. Cell 1991;64: 235-248.
3. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991;253:49-53.
4. Lane DP, Benchimol S. p53: oncogene or anti-oncogene? Genes & Develop 1990;4:1-8.
5. Bressac B, Galvin KM, Liang TJ, Isselbacher KJ, Wands JR. Abnormal structure and expression of p53 gene in human heptatocellular carcinoma. Proc Natl Acad Sci USA 1990;87:1973-1977.
6. Dolcetti R, Maestro R, Feriotto G, Pelucchi S, Rizzo S, Boiocchi M. p53 genetic abnormalities in human squamous cell carcinomas of the larynx. Oncogene 1990;6:44-45.
7. Rodrigues NR, Rowan A, Smith MEF, et al. p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 1990;87:7555-7559.
8. Nigro JM, Baker SJ, Preisinger AC, et al. Mutations in the p53 gene occur in diverse human tumor types. Nature 1989;342:705-708.
9. Takahashi T, Nau MM, Chiba I, et al. p53: a frequent target for genetic abnormalities in lung cancer. Science 1989;246:491-494.
10. Mukhopadhyay T, Cavender A, Tainsky M, Roth JA. Expression of antisense K-ras message in a human lung cancer cell line with a spontaneous activated K-ras oncogene alters the transformed phenotype. Proc Amer Assoc Cancer Res 1990;31:304.
11. Meltzer SJ, Yin J, Huang Y, et al. Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction. Proc Natl Acad Sci USA 1991;88:4976-4980.
12. Soriano P, Montgomery C, Geske R, Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991;64:693-702.
13. Chen P-L, Chen Y, Bookstein R, Lee W-H. Genetic mechanisms of tumor suppression by the human p53 gene. Science 1990;250: 1576-1580.
14. Yonish-Rouach E, Resnitzky D, Rotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 1991;352:345-347.
15. Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J. Induction orapoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA 1992;4495:4499.
16. Fujiwara T, Grimm EA, Mukhopadhyay T, Cai DW, Owen-Schaub LB, Roth JA. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res 1993;53:4129-4133.
17. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;74:957-967.
18. Humphrey EW, Smart CR, Winchester DP, et al. National survey of the pattern of care for carcinoma of the lung. J Thorac Cardiovasc Surg 1990;100(6):837-843.
19. Perez CA, Stanley K, Rubin P, et al. Patterns of tumor recurrence after definitive irradiation for inoperable non-oat cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 1980;6:987-994.
20. Komaki R, Garden AS, Cundiff JH. Endobronchial Radiotherapy. In: Roth JA, Hong WK, Cox JD, eds. Advances in Lung Cancer. Cambridge, MA: Blackwell Scientific Publications, Inc. 1992:
21. Boshart M, Weber F, Jahn G, Dorsch-Hasler K, Fleckenstein B, Schaffner W. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 1985;41: 521-530.
22. Mcgrory WJ, Bautista DS, Graham FL. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 1988;163:614-617.
23. Zhang WW, Fang X, Branch CD, Mazur W, French BA, Roth JA. Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis. BioTechniques 1993;15:868-872.
24. Graham FL, Prevec L. Manipulation of adenovirus vectors. In: Murray EJ, ed. Methods in Molecular Biology, Gene Transfer and Expression Protocols. New Jersey: The Humana Press Inc, 1991:109-128.
25. Dai Y, Roman M, Naviaux RK, Verma IM. Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo. Proc Natl Acad Sci USA 1993;89:10892-10895.
26. Georges RN, Mukhopadhyay T, Zhang YJ, Yen N, Roth JA. Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct. Cancer Res 1993;53:1743-1746.
27. Casson AG, Mukhopadhyay T, Cleary KR, Ro JY, Levin B, Roth JA. p53 gene mutations in Darrett's epithelium and esophageal cancer. Cancer Res 1991;51:4495-4499.